< Back To Leaders

Dalvir Gill

Dalvir Gill

Chief Executive Officer, TransCelerate BioPharma Inc.

Dalvir Gill, PhD, is the Chief Executive Officer of TransCelerate and serves on its Board of Directors. 
 
Dr. Gill has more than 25 years of drug development experience. Prior to his appointment as CEO of TransCelerate in December 2012, Dr. Gill was the President of Phase II-IV Drug Development at PharmaNet-i3, an international contract research organization. In this role, he was responsible for a global business spanning nearly 40 countries and had P&L responsibility for all operational departments and business development. 
 
Dr. Gill earned his BSc in Applied Biology from the University of Hertfordshire and his PhD in Pathobiology from the Royal Free Hospital School of Medicine, University of London. He also holds a diploma in the health economics of pharmaceuticals from the executive program of the Stockholm School of Economics. Dr. Gill has presented his research and spoken at numerous conferences, and has authored more than 30 scientific publications. He also is an elected fellow of the Royal Society of Medicine. 

Translate »

Stay Connected to Transcelerate.